T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop Leukemia's return after transplant
Disease control OngoingThis study is testing whether adding two drugs, venetoclax and azacitidine, after a stem cell transplant can help prevent high-risk leukemia from returning. It is for adults aged 18-75 with certain types of acute leukemia who have already had a transplant. The goal is to see if t…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Major trial seeks gentler, effective leukemia treatment for kids
Disease control OngoingThis trial is for children and young adults with a specific, aggressive type of leukemia (Ph+ ALL). It tests whether a standard chemotherapy regimen works as well as a stronger one when both are given with the targeted drug imatinib, aiming to maintain high cure rates while reduc…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC